DDIS-25. PENTAMIDINE; A NEW CHEMOTHERAPY TARGETING ON GLIOMA STEM LIKE CELLS

INTRODUCTION: Glioblastoma (GBM) is the most common primary malignant brain tumors. Despite aggressive therapies, median overall survival of patients who suffered from GBM is only 18 months. Furthermore, there is no effective therapy for glioma stem cells (GSCs), which act as forming tumors. Herein,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Tamai, Sho, Jiapaer, Shabierjiang, Zhang, Guangtao, Zhang, Jiakang, Wang, Yi, Sabit, Hemragul, Tanaka, Shingo, Kinoshita, Masashi, Hirao, Atsushi, Nakada, Mitsutoshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Drug Discovery
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847863/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.276
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller